Related Experiment Video

Updated: Jan 17, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.0K

'Pathology is disease' Parkinson's mythology: The 'brain-first-body-first' case study

Alberto J Espay1, Andrew J Lees2

  • 1James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH, USA.

Journal of Parkinson'S Disease
|September 18, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.2K
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.5K

Related Experiment Videos

Last Updated: Jan 17, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
04:49

Technique for Intranasal Administration of α-Synuclein Aggregates

Published on: November 8, 2024

1.0K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.2K
Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

10.5K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Neural Regulation01:37

Neural Regulation

43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987

Articles linked to this work by shared authors, journal, and citation graph.

Comparison of double-blind and open-label decline rates in lecanemab and donanemab trials in Alzheimer's disease.

BMJ neurology open·2026

Bridging the global Parkinson's divide: Technology as a structural solution for equitable and brain health-integrated care.

Journal of Parkinson's disease·2026

Systematic review of movement disorders mislabeled as functional: when incongruence misleads.

Journal of neurology·2026

Handwriting patterns in isolated rapid eye movement sleep behaviour disorder.

Journal of Parkinson's disease·2026

Computer Vision Analysis for Objective Motor Assessment in Parkinson's Disease: A Retrospective Study.

Movement disorders clinical practice·2025

Assessing Digital Health Technologies for Outcome Measurement in Parkinson's Disease Drug Trials: A Systematic Review.

Movement disorders : official journal of the Movement Disorder Society·2025

Optimizing participant recruitment and retention in clinical studies by hearing the voice of persons with Parkinson's.

Journal of Parkinson's disease·2026

Prevalence, predictors, and emerging biomarkers for cognitive impairment and neuropsychiatric manifestations in Parkinson's disease in Africa: A systematic review.

Journal of Parkinson's disease·2026

Environmental hazards and climate change: Unmasking Parkinson's hidden enemies.

Journal of Parkinson's disease·2026

PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens-associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease.

Journal of Parkinson's disease·2026

Cognitive-behavioral therapy in people with Parkinson's disease and caregivers: A mixed method systematic review on clinical applications and therapeutic outcomes.

Journal of Parkinson's disease·2026

A qPCR-based approach targeting the microbial gene marker nanA of mucin-degrading Akkermansia in Parkinson's disease.

Journal of Parkinson's disease·2026

High-altitude polycythemia: State-of-the-art review.

Therapeutic advances in hematology·2026

Effects of functional versus conventional Physiotherapy-Based pain management on symptoms, psychological outcomes, and quality of life in women with Bladder Pain Syndrome: A Randomized Controlled Trial.

Physiotherapy theory and practice·2026

Operative Exploration Versus Selective Nonsurgical Management in Hemodynamically Stable Patients With Penetrating Upper-Extremity Trauma: A Study in a Federally Qualified Health Center.

Journal of hand surgery global online·2026

Pain Point Elimination Bringing Better Longitudinal Engagement and Satisfaction project: qualitative mixed-methods study investigating a pragmatic intervention on physician well-being.

BJA open·2026

Hemodynamic resilience and enhanced early recovery with fospropofol versus propofol in high-BMI patients undergoing surgery: a randomised controlled trial.

Frontiers in surgery·2026

Relationship between intra-thoracic and -amniotic pressures and the impact of amnioreduction on thoraco-amniotic shunting efficacy: Insights from a case series.

European journal of obstetrics & gynecology and reproductive biology: X·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us